Advertising Agencies
Compare Stocks
4 / 10Stock Comparison
DRCT vs DV vs MGNI vs IAS
Revenue, margins, valuation, and 5-year total return — side by side.
Software - Application
Advertising Agencies
Advertising Agencies
DRCT vs DV vs MGNI vs IAS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Advertising Agencies | Software - Application | Advertising Agencies | Advertising Agencies |
| Market Cap | $3M | $1.76B | $2.01B | $1.74B |
| Revenue (TTM) | $35M | $764M | $723M | $591M |
| Net Income (TTM) | $-19M | $55M | $159M | $47M |
| Gross Margin | 30.0% | 82.2% | 63.4% | 77.4% |
| Operating Margin | -42.5% | 11.5% | 14.8% | 11.1% |
| Forward P/E | — | 20.5x | 13.4x | 27.5x |
| Total Debt | $13M | $100M | $279M | $58M |
| Cash & Equiv. | $728K | $259M | $553M | $84M |
DRCT vs DV vs MGNI vs IAS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Feb 22 | May 26 | Return |
|---|---|---|---|
| Direct Digital Hold… (DRCT) | 100 | 1.3 | -98.7% |
| DoubleVerify Holdin… (DV) | 100 | 39.2 | -60.8% |
| Magnite, Inc. (MGNI) | 100 | 96.0 | -4.0% |
| Integral Ad Science… (IAS) | 100 | 54.9 | -45.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: DRCT vs DV vs MGNI vs IAS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
DRCT is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 1 yrs, beta 0.40
- Beta 0.40 vs MGNI's 1.63
DV is the clearest fit if your priority is growth exposure.
- Rev growth 13.9%, EPS growth -6.3%, 3Y rev CAGR 18.3%
- 13.9% revenue growth vs DRCT's -44.3%
MGNI carries the broadest edge in this set and is the clearest fit for long-term compounding.
- -4.7% 10Y total return vs IAS's -49.8%
- Lower P/E (13.4x vs 27.5x)
- 22.0% margin vs DRCT's -54.6%
- 5.3% ROA vs DRCT's -84.4%, ROIC 9.5% vs -108.9%
IAS is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 0.83, Low D/E 5.7%, current ratio 3.02x
- Beta 0.83, current ratio 3.02x
- +40.1% vs DRCT's -96.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 13.9% revenue growth vs DRCT's -44.3% | |
| Value | Lower P/E (13.4x vs 27.5x) | |
| Quality / Margins | 22.0% margin vs DRCT's -54.6% | |
| Stability / Safety | Beta 0.40 vs MGNI's 1.63 | |
| Dividends | Tie | None of these 4 stocks pay a meaningful dividend |
| Momentum (1Y) | +40.1% vs DRCT's -96.9% | |
| Efficiency (ROA) | 5.3% ROA vs DRCT's -84.4%, ROIC 9.5% vs -108.9% |
DRCT vs DV vs MGNI vs IAS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
Segment breakdown not available.
DRCT vs DV vs MGNI vs IAS — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MGNI leads in 2 of 6 categories
DRCT leads 0 • DV leads 0 • IAS leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — DV and MGNI and IAS each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DV is the larger business by revenue, generating $764M annually — 22.0x DRCT's $35M. MGNI is the more profitable business, keeping 22.0% of every revenue dollar as net income compared to DRCT's -54.6%. On growth, IAS holds the edge at +15.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $35M | $764M | $723M | $591M |
| EBITDAEarnings before interest/tax | -$12M | $148M | $145M | $125M |
| Net IncomeAfter-tax profit | -$19M | $55M | $159M | $47M |
| Free Cash FlowCash after capex | -$9M | $135M | $44M | $165M |
| Gross MarginGross profit ÷ Revenue | +30.0% | +82.2% | +63.4% | +77.4% |
| Operating MarginEBIT ÷ Revenue | -42.5% | +11.5% | +14.8% | +11.1% |
| Net MarginNet income ÷ Revenue | -54.6% | +7.2% | +22.0% | +7.9% |
| FCF MarginFCF ÷ Revenue | -25.9% | +17.7% | +6.1% | +27.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | -7.4% | +9.6% | +5.5% | +15.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -41.1% | +3.0% | +142.9% | -57.4% |
Valuation Metrics
Evenly matched — DRCT and DV and MGNI each lead in 2 of 6 comparable metrics.
Valuation Metrics
At 14.7x trailing earnings, MGNI trades at a 67% valuation discount to IAS's 45.0x P/E. On an enterprise value basis, MGNI's 11.4x EV/EBITDA is more attractive than IAS's 13.7x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $3M | $1.8B | $2.0B | $1.7B |
| Enterprise ValueMkt cap + debt − cash | $16M | $1.6B | $1.7B | $1.7B |
| Trailing P/EPrice ÷ TTM EPS | -0.06x | 36.17x | 14.74x | 44.96x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 20.52x | 13.45x | 27.54x |
| PEG RatioP/E ÷ EPS growth rate | — | 1.99x | — | — |
| EV / EBITDAEnterprise value multiple | — | 11.77x | 11.43x | 13.74x |
| Price / SalesMarket cap ÷ Revenue | 0.09x | 2.35x | 2.81x | 3.27x |
| Price / BookPrice ÷ Book value/share | — | 1.60x | 2.33x | 1.70x |
| Price / FCFMarket cap ÷ FCF | — | 10.18x | 12.11x | 22.44x |
Profitability & Efficiency
MGNI leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
MGNI delivers a 18.6% return on equity — every $100 of shareholder capital generates $19 in annual profit, vs $4 for IAS. IAS carries lower financial leverage with a 0.06x debt-to-equity ratio, signaling a more conservative balance sheet compared to MGNI's 0.30x. On the Piotroski fundamental quality scale (0–9), MGNI scores 6/9 vs DRCT's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +5.0% | +18.6% | +4.2% |
| ROA (TTM)Return on assets | -84.4% | +4.2% | +5.3% | +3.9% |
| ROICReturn on invested capital | -108.9% | +6.4% | +9.5% | +4.6% |
| ROCEReturn on capital employed | -4.6% | +6.6% | +7.3% | +5.5% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 6 | 6 |
| Debt / EquityFinancial leverage | — | 0.09x | 0.30x | 0.06x |
| Net DebtTotal debt minus cash | $12M | -$159M | -$275M | -$27M |
| Cash & Equiv.Liquid assets | $728,000 | $259M | $553M | $84M |
| Total DebtShort + long-term debt | $13M | $100M | $279M | $58M |
| Interest CoverageEBIT ÷ Interest expense | -4.49x | 43.16x | 4.03x | 93.78x |
Total Returns (Dividends Reinvested)
MGNI leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IAS five years ago would be worth $5,024 today (with dividends reinvested), compared to $72 for DRCT. Over the past 12 months, IAS leads with a +40.1% total return vs DRCT's -96.9%. The 3-year compound annual growth rate (CAGR) favors MGNI at 16.7% vs DRCT's -80.5% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -61.9% | -0.1% | -12.8% | — |
| 1-Year ReturnPast 12 months | -96.9% | -19.9% | +12.6% | +40.1% |
| 3-Year ReturnCumulative with dividends | -99.3% | -60.1% | +58.7% | -39.0% |
| 5-Year ReturnCumulative with dividends | -99.3% | -70.2% | -60.9% | -49.8% |
| 10-Year ReturnCumulative with dividends | -99.3% | -68.9% | -4.7% | -49.8% |
| CAGR (3Y)Annualised 3-year return | -80.5% | -26.4% | +16.7% | -15.2% |
Risk & Volatility
Evenly matched — DRCT and IAS each lead in 1 of 2 comparable metrics.
Risk & Volatility
DRCT is the less volatile stock with a 0.40 beta — it tends to amplify market swings less than MGNI's 1.63 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IAS currently trades 100.0% from its 52-week high vs DRCT's 2.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.40x | 1.03x | 1.63x | 0.83x |
| 52-Week HighHighest price in past year | $179.32 | $16.82 | $26.65 | $10.34 |
| 52-Week LowLowest price in past year | $2.17 | $7.64 | $10.82 | $7.29 |
| % of 52W HighCurrent price vs 52-week peak | +2.6% | +64.5% | +52.5% | +100.0% |
| RSI (14)Momentum oscillator 0–100 | 81.4 | 61.2 | 55.4 | 67.5 |
| Avg Volume (50D)Average daily shares traded | 257K | 2.6M | 2.1M | 0 |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Analyst consensus: DV as "Buy", MGNI as "Buy", IAS as "Buy". Consensus price targets imply 39.2% upside for DV (target: $15) vs 28.6% for MGNI (target: $18).
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $15.10 | $18.00 | $14.29 |
| # AnalystsCovering analysts | — | 33 | 31 | 12 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | — |
| Dividend StreakConsecutive years of raises | 1 | — | — | — |
| Dividend / ShareAnnual DPS | — | — | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +8.1% | +2.3% | 0.0% |
MGNI leads in 2 of 6 categories — strongest in Profitability & Efficiency and Total Returns. 3 categories are tied.
DRCT vs DV vs MGNI vs IAS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is DRCT or DV or MGNI or IAS a better buy right now?
For growth investors, DoubleVerify Holdings, Inc.
(DV) is the stronger pick with 13. 9% revenue growth year-over-year, versus -44. 3% for Direct Digital Holdings, Inc. (DRCT). Magnite, Inc. (MGNI) offers the better valuation at 14. 7x trailing P/E (13. 4x forward), making it the more compelling value choice. Analysts rate DoubleVerify Holdings, Inc. (DV) a "Buy" — based on 33 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — DRCT or DV or MGNI or IAS?
On trailing P/E, Magnite, Inc.
(MGNI) is the cheapest at 14. 7x versus Integral Ad Science Holding Corp. at 45. 0x. On forward P/E, Magnite, Inc. is actually cheaper at 13. 4x.
03Which is the better long-term investment — DRCT or DV or MGNI or IAS?
Over the past 5 years, Integral Ad Science Holding Corp.
(IAS) delivered a total return of -49. 8%, compared to -99. 3% for Direct Digital Holdings, Inc. (DRCT). Over 10 years, the gap is even starker: MGNI returned -4. 7% versus DRCT's -99. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — DRCT or DV or MGNI or IAS?
By beta (market sensitivity over 5 years), Direct Digital Holdings, Inc.
(DRCT) is the lower-risk stock at 0. 40β versus Magnite, Inc. 's 1. 63β — meaning MGNI is approximately 305% more volatile than DRCT relative to the S&P 500. On balance sheet safety, Integral Ad Science Holding Corp. (IAS) carries a lower debt/equity ratio of 6% versus 30% for Magnite, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — DRCT or DV or MGNI or IAS?
By revenue growth (latest reported year), DoubleVerify Holdings, Inc.
(DV) is pulling ahead at 13. 9% versus -44. 3% for Direct Digital Holdings, Inc. (DRCT). On earnings-per-share growth, the picture is similar: Magnite, Inc. grew EPS 493. 8% year-over-year, compared to -44. 7% for Direct Digital Holdings, Inc.. Over a 3-year CAGR, DV leads at 18. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — DRCT or DV or MGNI or IAS?
Magnite, Inc.
(MGNI) is the more profitable company, earning 20. 3% net margin versus -54. 6% for Direct Digital Holdings, Inc. — meaning it keeps 20. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MGNI leads at 13. 7% versus -42. 5% for DRCT. At the gross margin level — before operating expenses — DV leads at 82. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is DRCT or DV or MGNI or IAS more undervalued right now?
On forward earnings alone, Magnite, Inc.
(MGNI) trades at 13. 4x forward P/E versus 27. 5x for Integral Ad Science Holding Corp. — 14. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DV: 39. 2% to $15. 10.
08Which pays a better dividend — DRCT or DV or MGNI or IAS?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is DRCT or DV or MGNI or IAS better for a retirement portfolio?
For long-horizon retirement investors, Direct Digital Holdings, Inc.
(DRCT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 40)). Magnite, Inc. (MGNI) carries a higher beta of 1. 63 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DRCT: -99. 3%, MGNI: -4. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between DRCT and DV and MGNI and IAS?
These companies operate in different sectors (DRCT (Communication Services) and DV (Technology) and MGNI (Communication Services) and IAS (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: DRCT is a small-cap quality compounder stock; DV is a small-cap quality compounder stock; MGNI is a small-cap deep-value stock; IAS is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.